Latest News about BMY
Recent news which mentions BMY
3 Desirable Drug Stocks With Very Promising Pipelines
February 16, 2022
Tags
Hot Stocks
NASDAQ:HRMY,NASDAQ:SDGR,NASDAQ:PTGX,NYSEARCA:XBI,NASDAQ:SNY,NYSE:BMY,NASDAQ:AGIO,NYSE:JNJ
PTGX
From InvestorPlace
Inside Gilead's Lackluster $7.2 Billion Q4 Earnings
February 16, 2022
From Motley Fool
Bristol Myers, Exelixis Tout Additional Opdivo/Cabometyx Combo Data From Kidney Cancer Trial
February 15, 2022
From Benzinga
3 Top Biotech Stocks to Buy Right Now
February 15, 2022
From Motley Fool
Got $1,000? 5 Buffett Stocks to Buy and Hold Forever
February 14, 2022
From Motley Fool
6 Companies That Recently Announced Large Buybacks
February 10, 2022
From Benzinga
The Daily Biotech Pulse: Bristol-Myers Squibb Announces $5B Accelerated Buyback, Qiagen Reaps COVID Testing Windfall, WORLDSymposium Presentations Kick In
February 09, 2022
From Benzinga
2 Natural-Killer Cell Therapy Oncology Companies Investors Should Watch
February 08, 2022
From Benzinga
2 Healthcare Stocks That Could Help Make You a Fortune
February 08, 2022
From Motley Fool
3 Warren Buffett Stocks to Buy Hand Over Fist in February
February 07, 2022
From Motley Fool
Bristol-Myers Squibb (BMY) Q4 2021 Earnings Call Transcript
February 04, 2022
Tickers
BMY
From Motley Fool
5 Biotech Stocks to Buy to Benefit From Biden’s New Cancer Cabinet
February 04, 2022
From InvestorPlace
Bristol Myers Q4 Revenue, FY22 Sales Outlook Lag Consensus
February 04, 2022
Tickers
BMY
From Benzinga
The Daily Biotech Pulse: Sanofi, Bristol-Myers Squibb Gain On Earnings, Valneva-Pfizer Tout Positive Lyme Disease Vaccine Data, UNITY Biotech Restructures
February 04, 2022
From Benzinga
5 Stocks To Watch For February 4, 2022
February 04, 2022
From Benzinga
Earnings Scheduled For February 4, 2022
February 04, 2022
From Benzinga
Psoriasis Drug Providers Looking Over Shoulders At Upcoming Competitor?
February 03, 2022
From Benzinga
The Daily Biotech Pulse: Big Pharma Earnings Prove Lackluster, Mersana Inks $1B ADC R&D Deal, Syros Gets Orphan Drug Designation
February 03, 2022
From Benzinga
Amendments To Canada's Special Access Program (SAP) Allows Access To Restricted Psychedelic Drugs. How Will This Affect The Industry?
February 02, 2022
From Benzinga
3 Pharmaceutical Stocks With Dividend Yields of 2.9% or Better
February 01, 2022
From Motley Fool
5 Things To Expect This Week
January 31, 2022
From InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
January 31, 2022
From Benzinga
Are Warren Buffett's 3 Cheapest Stocks Screaming Buys?
January 31, 2022
From Motley Fool
How to Invest in Biotech When Deep Value Has no Discernible Meaning
January 31, 2022
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.